Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tri-Ax
- Development stage
- Unknown
- Lead developer
- Halberd
- Modality
- Small Molecules
- Administration
- Intranasal
01
Overview
Tri-Ax™ (Halberd nasal spray) is a patent-pending, multi-part therapeutic formulation being developed by Halberd Corporation for the treatment of traumatic brain injury (TBI) and related neurodegenerative conditions. The drug is designed for rapid, point-of-injury administration via an intranasal route, potentially using an auto-nasal injector developed in partnership with Athena GTX. Its mechanism of action involves the inhibition of excess inflammatory cytokines and the blocking of specific proteins that are overproduced following head trauma, which helps to mitigate secondary brain damage and support natural recovery. The product has undergone Phase II animal testing at Mississippi State University, demonstrating efficacy in improving motor activity post-impact. Beyond TBI, the company is exploring its application in PTSD, Alzheimer's disease, and epilepsy.
- Brand names
- Tri-Ax
- Other names
- Halberd nasal spray
Beyond the preview
Go deeper on Tri-Ax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tri-Ax.